Literature DB >> 168038

The current status of prostaglandins and the lungs.

J O Shaw, K M Moser.   

Abstract

The prostaglandins are a group of pharmacologically potent lipid compounds whose role in pulmonary pathophysiology remains to be defined. There is not question that these compounds can induce constriction (PGF) or relaxation (PGE) of the smooth muscle in bronchi and pulmonary vessels. There is no question that the lungs are a major site of both the synthesis and degradation. These facts make speculation about the role of the prostaglandins in pulmonary disorders a tempting exercise. However, the current paucity of clinical data prevents any valid assessment of such speculation at this time and emphasizes the need for continued investigation of the role of prostaglandins in patients with lung disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168038     DOI: 10.1378/chest.68.1.75

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Pattern of total and regional lung function in subjects with bronchoconstriction induced by 15-me PGF2 alpha.

Authors:  L H Andersen; N J Secher
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

2.  Regulatory pathways for the stimulation of canine tracheal ciliary beat frequency by bradykinin.

Authors:  L B Wong; I F Miller; D B Yeates
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.